Johnson & Johnson says its vaccine is 66% effective overall

That's not….great
The shares of JNJ tell the story, down to $161 from $169 at the close yesterday.
The nightmare scenario here is that covid never goes away and continues to mutate until it's a situation like the regular flu, where you're getting a shot every year but it's only moderately effective. Especially worrisome is the South